ARIPIPRAZOLE LAUROXIL

ARIPIPRAZOLE LAUROXIL was reported 4608 times

ARIPIPRAZOLE LAUROXIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE JOINT MOVEMENT IMPAIRMENT 1 0.5000
1 BOOSTER DOSE MISSED 1 0.2500
2 DELUSIONAL DISORDER, GRANDIOSE TYPE 1 0.1429
3 FAILED EXAMINATIONS 2 0.1176
4 IMPERFORATE HYMEN 1 0.0833
5 PRODUCT ADMINISTERED BY WRONG PERSON 29 0.0759
6 EGOCENTRISM 2 0.0714
7 TACITURNITY 6 0.0682
8 DELINQUENCY 1 0.0526
9 SCHIZOAFFECTIVE DISORDER DEPRESSIVE TYPE 2 0.0476
10 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 10 0.0435
11 INJECTED LIMB MOBILITY DECREASED 6 0.0420
12 ALEXITHYMIA 2 0.0400
13 DEATH OF COMPANION 1 0.0385
14 PERSONAL RELATIONSHIP ISSUE 23 0.0344
15 LACK OF ADMINISTRATION SITE ROTATION 9 0.0295
16 INJECTION SITE MOVEMENT IMPAIRMENT 3 0.0234
17 EXERCISE TOLERANCE INCREASED 1 0.0233
18 NEEDLE ISSUE 667 0.0229
19 ALCOHOL TEST POSITIVE 1 0.0213
20 PSYCHIATRIC DECOMPENSATION 38 0.0194
21 SOLILOQUY 16 0.0185
22 SUSPICIOUSNESS 13 0.0185
23 PRODUCT SUBSTITUTION ERROR 2 0.0171
24 INJECTION SITE NERVE DAMAGE 4 0.0167
25 ALCOHOLIC HANGOVER 1 0.0164
26 INTENTIONAL REMOVAL OF DRUG DELIVERY SYSTEM BY PATIENT 1 0.0154
27 GASTROINTESTINAL NEUROENDOCRINE TUMOUR 1 0.0154
28 FEAR OF CROWDED PLACES 1 0.0149
29 HOSTILITY 37 0.0145
30 CAFFEINE CONSUMPTION 1 0.0145
31 CONSTRICTED AFFECT 1 0.0143
32 IMPERCEPTION 1 0.0141
33 EXHIBITIONISM 1 0.0139
34 INJECTION SITE CYST 4 0.0137
35 SEXUALLY INAPPROPRIATE BEHAVIOUR 6 0.0129
36 PSYCHOTIC SYMPTOM 26 0.0126
37 PRODUCT PHYSICAL CONSISTENCY ISSUE 68 0.0123
38 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 219 0.0119
39 HALLUCINATION, AUDITORY 175 0.0110
40 SYRINGE ISSUE 174 0.0099
41 IRREGULAR SLEEP WAKE RHYTHM DISORDER 2 0.0099
42 IDEAS OF REFERENCE 1 0.0098
43 LACK OF INJECTION SITE ROTATION 17 0.0097
44 CONDUCT DISORDER 2 0.0097
45 POOR PERSONAL HYGIENE 5 0.0097
46 MALABSORPTION FROM INJECTION SITE 3 0.0097
47 SUBSTANCE USE 15 0.0096
48 PRODUCT RECONSTITUTION ISSUE 3 0.0095
49 SCHIZOPHRENIA 104 0.0085
50 IRON METABOLISM DISORDER 1 0.0084
51 ANTISOCIAL PERSONALITY DISORDER 1 0.0078
52 MANUFACTURING MATERIALS ISSUE 3 0.0074
53 SOCIAL AVOIDANT BEHAVIOUR 43 0.0074
54 SCHIZOAFFECTIVE DISORDER 13 0.0073
55 HALLUCINATION, OLFACTORY 3 0.0069
56 GAMBLING 8 0.0069
57 EMOTIONAL POVERTY 12 0.0068
58 PERSECUTORY DELUSION 17 0.0068
59 PRODUCT LEAKAGE 38 0.0068
60 DELUSIONAL DISORDER, UNSPECIFIED TYPE 5 0.0067
61 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0066
62 HISTRIONIC PERSONALITY DISORDER 1 0.0066
63 FACTITIOUS DISORDER 1 0.0066
64 BRUCELLOSIS 1 0.0066
65 FEAR-RELATED AVOIDANCE OF ACTIVITIES 1 0.0066
66 ATTENTION-SEEKING BEHAVIOUR 1 0.0064
67 DUPLICATE THERAPY ERROR 2 0.0062
68 PRESSURE OF SPEECH 4 0.0062
69 CYCLOTHYMIC DISORDER 1 0.0061
70 HAND-EYE COORDINATION IMPAIRED 1 0.0059
71 PSYCHOTIC BEHAVIOUR 6 0.0059
72 ALCOHOL USE DISORDER 1 0.0058
73 INJECTION SITE HYPOAESTHESIA 8 0.0056
74 THERAPEUTIC RESPONSE SHORTENED 182 0.0055
75 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0054
76 PRODUCT CLOSURE ISSUE 3 0.0054
77 AKATHISIA 73 0.0053
78 COMPULSIVE SHOPPING 11 0.0053
79 PARANOIA 91 0.0053
80 HYPOMETABOLISM 2 0.0052
81 IMPRISONMENT 9 0.0051
82 INAPPROPRIATE AFFECT 8 0.0050
83 EXCESSIVE MASTURBATION 1 0.0048
84 LACTATION INSUFFICIENCY 1 0.0048
85 DELUSION 75 0.0048
86 CRYSTAL ARTHROPATHY 1 0.0048
87 DISSOCIATIVE IDENTITY DISORDER 1 0.0048
88 TOBACCO USER 7 0.0047
89 GENITAL DISORDER MALE 1 0.0047
90 BELLIGERENCE 2 0.0047
91 BINGE EATING 5 0.0046
92 WRONG DEVICE USED 3 0.0046
93 SOCIAL ANXIETY DISORDER 3 0.0046
94 FACIAL SPASM 5 0.0045
95 HYPERSEXUALITY 8 0.0044
96 INCORRECT DOSE ADMINISTERED BY PRODUCT 7 0.0044
97 TACHYPHRENIA 15 0.0043
98 PRODUCT ADMINISTRATION ERROR 86 0.0043
99 INJECTION SITE GRANULOMA 1 0.0042
100 INJECTION SITE INDURATION 54 0.0042
101 LACTATION DISORDER 2 0.0041
102 PSYCHOTIC DISORDER 120 0.0041
103 HYPONATRAEMIC SEIZURE 1 0.0039
104 INJECTION SITE MASS 145 0.0039
105 CORONAVIRUS TEST POSITIVE 4 0.0039
106 VICTIM OF SEXUAL ABUSE 2 0.0038
107 INJECTION SITE DISCOMFORT 40 0.0038
108 CRIME 1 0.0038
109 HYPERMETABOLISM 2 0.0038
110 ANTIPSYCHOTIC DRUG LEVEL DECREASED 2 0.0038
111 IMPATIENCE 7 0.0037
112 COMPULSIVE SEXUAL BEHAVIOUR 3 0.0037
113 TONGUE MOVEMENT DISTURBANCE 3 0.0035
114 MANIA 57 0.0035
115 FLAT AFFECT 8 0.0035
116 HOMICIDAL IDEATION 14 0.0034
117 LIBIDO INCREASED 7 0.0034
118 GAMBLING DISORDER 9 0.0033
119 HYPERPHAGIA 13 0.0033
120 FEAR OF EATING 1 0.0032
121 ECHOLALIA 1 0.0031
122 DRUG ADMINISTERED AT INAPPROPRIATE SITE 33 0.0031
123 HAEMATOLOGY TEST ABNORMAL 1 0.0031
124 ASOCIAL BEHAVIOUR 1 0.0031
125 ANOREXIA NERVOSA 1 0.0031
126 INJECTION SITE HYPERTROPHY 1 0.0031
127 BENIGN HYDATIDIFORM MOLE 1 0.0030
128 THEFT 2 0.0030
129 COMPULSIONS 2 0.0030
130 ANTISOCIAL BEHAVIOUR 3 0.0030
131 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 139 0.0030
132 BOREDOM 1 0.0029
133 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 2 0.0029
134 HALLUCINATIONS, MIXED 12 0.0029
135 INJECTION SITE SCAR 8 0.0028
136 DISSOCIATIVE DISORDER 2 0.0028
137 JUDGEMENT IMPAIRED 4 0.0028
138 BIPOLAR I DISORDER 6 0.0027
139 GRANDIOSITY 1 0.0027
140 LEGAL PROBLEM 2 0.0027
141 PSYCHIATRIC SYMPTOM 20 0.0027
142 SKIN STRIAE 4 0.0027
143 BODY DYSMORPHIC DISORDER 1 0.0027
144 NEGATIVISM 2 0.0026
145 IMPAIRED REASONING 1 0.0026
146 HYPEREMESIS GRAVIDARUM 1 0.0026
147 DAYDREAMING 4 0.0026
148 MORBID THOUGHTS 3 0.0026
149 LOGORRHOEA 9 0.0026
150 INTRUSIVE THOUGHTS 3 0.0025
151 GRANULOCYTE COUNT INCREASED 1 0.0025
152 DELUSIONAL PERCEPTION 1 0.0024
153 DELUSIONAL DISORDER, PERSECUTORY TYPE 1 0.0024
154 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 1 0.0024
155 EXPOSURE VIA EYE CONTACT 1 0.0024
156 RESTLESSNESS 86 0.0023
157 OCULOGYRIC CRISIS 5 0.0023
158 DEREALISATION 5 0.0023
159 LOSS OF EMPLOYMENT 7 0.0023
160 UNDERDOSE 169 0.0023
161 INJECTION SITE INDENTATION 5 0.0023
162 BULIMIA NERVOSA 1 0.0023
163 LACK OF SPONTANEOUS SPEECH 1 0.0023
164 HOMELESS 1 0.0022
165 ENLARGED UVULA 1 0.0022
166 DELUSION OF GRANDEUR 1 0.0022
167 INFERTILITY MALE 1 0.0022
168 OCCUPATIONAL EXPOSURE TO PRODUCT 14 0.0022
169 DISORGANISED SPEECH 4 0.0022
170 EATING DISORDER SYMPTOM 1 0.0022
171 FEELING OF DESPAIR 10 0.0021
172 IMPULSIVE BEHAVIOUR 8 0.0021
173 THERAPEUTIC RESPONSE INCREASED 2 0.0021
174 APATHY 31 0.0021
175 COMMUNICATION DISORDER 8 0.0021
176 SUBSTANCE ABUSE 17 0.0021
177 HELPLESSNESS 1 0.0021
178 HYPERVIGILANCE 2 0.0021
179 EXERCISE LACK OF 1 0.0021
180 NEGATIVE THOUGHTS 6 0.0020
181 INJECTION SITE ABSCESS 5 0.0020
182 HYPOHIDROSIS 1 0.0020
183 INJECTION SITE PARAESTHESIA 3 0.0020
184 KELOID SCAR 1 0.0019
185 VIOLENCE-RELATED SYMPTOM 3 0.0019
186 AXILLARY MASS 2 0.0019
187 FLIGHT OF IDEAS 1 0.0019
188 FOCAL NODULAR HYPERPLASIA 1 0.0019
189 WRONG PRODUCT ADMINISTERED 13 0.0019
190 BODY TEMPERATURE FLUCTUATION 4 0.0019
191 PHYSICAL ASSAULT 4 0.0019
192 PERSONALITY DISORDER 5 0.0019
193 DRUG SCREEN POSITIVE 15 0.0019
194 ALCOHOL USE 7 0.0019
195 GRIEF REACTION 1 0.0019
196 NEUROMYOPATHY 2 0.0019
197 ALCOHOL ABUSE 5 0.0019
198 AUTOSCOPY 1 0.0019
199 SOMATIC SYMPTOM DISORDER 2 0.0019
200 RESTLESS LEGS SYNDROME 33 0.0018
201 DRUG ADMINISTRATION ERROR 54 0.0018
202 EUPHORIC MOOD 18 0.0018
203 BIPOLAR DISORDER 19 0.0017
204 DISTRACTIBILITY 2 0.0017
205 FLASHBACK 1 0.0017
206 AGITATION 126 0.0017
207 DISTURBANCE IN SOCIAL BEHAVIOUR 4 0.0017
208 TERMINAL INSOMNIA 3 0.0017
209 ADENOMYOSIS 1 0.0017
210 ABNORMAL BEHAVIOUR 67 0.0017
211 DERMATILLOMANIA 1 0.0017
212 OBSESSIVE THOUGHTS 3 0.0017
213 TIC 9 0.0016
214 SLOW SPEECH 4 0.0016
215 DROOLING 11 0.0016
216 DRUG LEVEL CHANGED 1 0.0016
217 THINKING ABNORMAL 29 0.0016
218 CONVERSION DISORDER 3 0.0015
219 SLOW RESPONSE TO STIMULI 2 0.0015
220 JOB DISSATISFACTION 1 0.0015
221 FEELINGS OF WORTHLESSNESS 2 0.0015
222 ENERGY INCREASED 9 0.0015
223 INCREASED APPETITE 29 0.0015
224 HALLUCINATION, VISUAL 32 0.0015
225 INTERCEPTED PRODUCT PRESCRIBING ERROR 2 0.0015
226 HALLUCINATION, TACTILE 1 0.0015
227 BODY MASS INDEX INCREASED 2 0.0015
228 AGGRESSION 74 0.0015
229 IMPULSE-CONTROL DISORDER 3 0.0015
230 IMPAIRED SELF-CARE 3 0.0014
231 SELF-INJURIOUS IDEATION 6 0.0014
232 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
233 TREATMENT NONCOMPLIANCE 78 0.0014
234 INJECTION SITE PAIN 436 0.0014
235 GLASSY EYES 1 0.0014
236 BORDERLINE PERSONALITY DISORDER 1 0.0014
237 FEAR OF INJECTION 10 0.0014
238 PRODUCT DISTRIBUTION ISSUE 13 0.0014
239 HALLUCINATION 105 0.0014
240 ANGER 47 0.0014
241 PRODUCT PHYSICAL ISSUE 28 0.0014
242 LIQUID PRODUCT PHYSICAL ISSUE 10 0.0014
243 DRUG-DISEASE INTERACTION 1 0.0014
244 CORONAVIRUS INFECTION 9 0.0014
245 BLUNTED AFFECT 1 0.0014
246 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 3 0.0013
247 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 23 0.0013
248 INDIFFERENCE 1 0.0013
249 OFF LABEL USE 1147 0.0013
250 GASTROINTESTINAL SURGERY 1 0.0013
251 PRODUCT DEPOSIT 2 0.0013
252 SUSPECTED SUICIDE 6 0.0013
253 INJECTION SITE NODULE 14 0.0013
254 EYELID FUNCTION DISORDER 1 0.0013
255 WEIGHT ABNORMAL 3 0.0012
256 PREGNANCY 25 0.0012
257 OBSESSIVE-COMPULSIVE DISORDER 10 0.0012
258 DISINHIBITION 2 0.0012
259 FEAR OF FALLING 1 0.0012
260 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
261 NEUROLEPTIC MALIGNANT SYNDROME 14 0.0012
262 TRISMUS 6 0.0012
263 PRIAPISM 4 0.0012
264 GENITAL BURNING SENSATION 1 0.0012
265 HYPERSOMNIA 33 0.0011
266 SEDATION 30 0.0011
267 EMOTIONAL DISORDER 35 0.0011
268 JAW OPERATION 1 0.0011
269 INDURATION 2 0.0011
270 DECREASED ACTIVITY 12 0.0011
271 BONE CONTUSION 1 0.0011
272 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
273 HYPOMANIA 4 0.0011
274 MUSCLE TWITCHING 25 0.0011
275 HUNGER 15 0.0011
276 SKIN HYPERTROPHY 3 0.0011
277 INJECTION SITE ULCER 1 0.0011
278 BLOOD PROLACTIN INCREASED 5 0.0011
279 INJECTION SITE SCAB 1 0.0010
280 IRRITABILITY 62 0.0010
281 INJECTION SITE WARMTH 21 0.0010
282 BRAIN HYPOXIA 1 0.0010
283 DROWNING 1 0.0010
284 GASTRIC PH DECREASED 1 0.0010
285 WEIGHT INCREASED 218 0.0010
286 BLADDER DYSFUNCTION 1 0.0010
287 TONGUE BITING 2 0.0010
288 SOCIAL PROBLEM 4 0.0010
289 CATATONIA 5 0.0010
290 SLEEP TERROR 4 0.0009
291 HOSPITALISATION 145 0.0009
292 DYSKINESIA 38 0.0009
293 CLAUSTROPHOBIA 1 0.0009
294 ACARODERMATITIS 1 0.0009
295 IMMEDIATE POST-INJECTION REACTION 1 0.0009
296 PRODUCT LOT NUMBER ISSUE 2 0.0009
297 COGNITIVE DISORDER 42 0.0009
298 DEMENTIA WITH LEWY BODIES 1 0.0009
299 TEMPERATURE REGULATION DISORDER 2 0.0009
300 POST-TRAUMATIC STRESS DISORDER 6 0.0009
301 INCORRECT DOSE ADMINISTERED 202 0.0009
302 DRUG EFFECT VARIABLE 1 0.0009
303 SLUGGISHNESS 9 0.0009
304 IMPAIRED DRIVING ABILITY 10 0.0009
305 EYE MOVEMENT DISORDER 6 0.0009
306 READING DISORDER 2 0.0009
307 ADMINISTRATION SITE PAIN 1 0.0009
308 DYSLEXIA 1 0.0009
309 FRUSTRATION TOLERANCE DECREASED 7 0.0009
310 INCONTINENCE 9 0.0009
311 TARDIVE DYSKINESIA 24 0.0008
312 DECREASED INTEREST 5 0.0008
313 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
314 DRUG USE DISORDER 7 0.0008
315 STARING 2 0.0008
316 PRODUCT DOSE OMISSION 53 0.0008
317 INJECTION SITE INFLAMMATION 4 0.0008
318 SCREAMING 5 0.0008
319 THIRST 14 0.0008
320 CLAVICLE FRACTURE 3 0.0008
321 ADNEXA UTERI PAIN 1 0.0008
322 APGAR SCORE LOW 1 0.0008
323 GESTATIONAL HYPERTENSION 1 0.0008
324 REHABILITATION THERAPY 3 0.0008
325 INCOHERENT 5 0.0008
326 MOOD ALTERED 21 0.0008
327 SEXUAL DYSFUNCTION 9 0.0008
328 COMPARTMENT SYNDROME 2 0.0008
329 DRUG CLEARANCE DECREASED 1 0.0008
330 BRADYPHRENIA 5 0.0008
331 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
332 POLYDIPSIA 3 0.0008
333 PERSONALITY CHANGE 7 0.0008
334 YAWNING 2 0.0007
335 ALCOHOL POISONING 2 0.0007
336 OVERWEIGHT 4 0.0007
337 WEIGHT BEARING DIFFICULTY 2 0.0007
338 SUICIDAL IDEATION 68 0.0007
339 WRONG PATIENT RECEIVED MEDICATION 2 0.0007
340 AGORAPHOBIA 1 0.0007
341 HEAD TITUBATION 1 0.0007
342 PSYCHOMOTOR HYPERACTIVITY 12 0.0007
343 DRUG SCREEN FALSE POSITIVE 2 0.0007
344 AUDITORY DISORDER 1 0.0007
345 MENTAL IMPAIRMENT 17 0.0007
346 ALCOHOLISM 3 0.0007
347 FAT TISSUE INCREASED 1 0.0007
348 METABOLIC DISORDER 4 0.0007
349 BRADYKINESIA 4 0.0007
350 EXCESSIVE EYE BLINKING 1 0.0007
351 APRAXIA 1 0.0007
352 INTELLECTUAL DISABILITY 1 0.0007
353 HEAT STROKE 1 0.0007
354 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
355 TENSION 4 0.0007
356 INJECTION SITE SWELLING 50 0.0007
357 DISTURBANCE IN ATTENTION 35 0.0006
358 FAMILY STRESS 2 0.0006
359 MENTAL DISORDER 28 0.0006
360 HYPOTONIA NEONATAL 1 0.0006
361 INHIBITORY DRUG INTERACTION 1 0.0006
362 FEELING JITTERY 12 0.0006
363 DEPRESSED MOOD 33 0.0006
364 GALACTORRHOEA 4 0.0006
365 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
366 RASH VESICULAR 3 0.0006
367 MUSCLE TIGHTNESS 10 0.0006
368 PARKINSONISM 6 0.0006
369 SOMNAMBULISM 4 0.0006
370 INJECTION SITE INFECTION 2 0.0006
371 CRYING 22 0.0006
372 ILLUSION 1 0.0006
373 EXTRAPYRAMIDAL DISORDER 15 0.0006
374 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
375 TREMOR 100 0.0006
376 EDUCATIONAL PROBLEM 1 0.0006
377 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
378 WOUND DEHISCENCE 2 0.0006
379 FOOD AVERSION 1 0.0006
380 PRODUCT PREPARATION ERROR 12 0.0006
381 INJECTION SITE OEDEMA 1 0.0006
382 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 41 0.0006
383 COORDINATION ABNORMAL 8 0.0006
384 BREAST DISCHARGE 1 0.0006
385 FOOD CRAVING 3 0.0006
386 DRUG SCREEN NEGATIVE 1 0.0006
387 NECROTISING FASCIITIS 2 0.0006
388 MOOD SWINGS 18 0.0006
389 BEHAVIOUR DISORDER 3 0.0006
390 TONGUE DISORDER 4 0.0006
391 ANXIETY 156 0.0005
392 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
393 BODY TEMPERATURE ABNORMAL 1 0.0005
394 HOMICIDE 1 0.0005
395 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 110 0.0005
396 ARTHROPOD BITE 4 0.0005
397 FEELING DRUNK 4 0.0005
398 INJECTION SITE CELLULITIS 1 0.0005
399 GENERAL SYMPTOM 4 0.0005
400 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 95 0.0005
401 NEUROLOGICAL SYMPTOM 3 0.0005
402 AFFECT LABILITY 5 0.0005
403 DEPRESSION 118 0.0005
404 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
405 THERAPEUTIC RESPONSE DECREASED 31 0.0005
406 COLOSTOMY 1 0.0005
407 AFFECTIVE DISORDER 4 0.0005
408 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
409 SYMPTOM RECURRENCE 3 0.0005
410 INJECTION SITE HAEMORRHAGE 40 0.0005
411 CARDIAC DISCOMFORT 1 0.0005
412 INJECTION SITE VESICLES 3 0.0005
413 FOAMING AT MOUTH 1 0.0005
414 INTENTIONAL SELF-INJURY 10 0.0005
415 PRESYNCOPE 12 0.0005
416 INJURY ASSOCIATED WITH DEVICE 10 0.0005
417 INJECTION SITE NECROSIS 1 0.0005
418 MENSTRUAL DISORDER 4 0.0005
419 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
420 MIDDLE INSOMNIA 9 0.0005
421 INSULIN RESISTANCE 1 0.0005
422 SOMNOLENCE 96 0.0005
423 BLEPHAROSPASM 3 0.0005
424 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
425 MUSCULOSKELETAL DISCOMFORT 8 0.0005
426 DYSTONIA 9 0.0005
427 LANGUAGE DISORDER 1 0.0005
428 NERVOUSNESS 24 0.0005
429 ACCIDENT AT WORK 1 0.0005
430 APPETITE DISORDER 3 0.0005
431 LETHARGY 26 0.0005
432 FEAR 12 0.0004
433 FEAR OF DEATH 1 0.0004
434 PANIC ATTACK 16 0.0004
435 INJECTION SITE BRUISING 35 0.0004
436 FEELING ABNORMAL 105 0.0004
437 IMPLANT SITE INFECTION 1 0.0004
438 DISCOURAGEMENT 1 0.0004
439 INGROWING NAIL 1 0.0004
440 SLEEP APNOEA SYNDROME 8 0.0004
441 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
442 PANIC REACTION 3 0.0004
443 BREATH ODOUR 1 0.0004
444 HORMONE LEVEL ABNORMAL 2 0.0004
445 INCORRECT DOSAGE ADMINISTERED 2 0.0004
446 DERMAL CYST 1 0.0004
447 BLINDNESS TRANSIENT 3 0.0004
448 ACUTE PSYCHOSIS 1 0.0004
449 FLUID INTAKE REDUCED 2 0.0004
450 BREAST TENDERNESS 3 0.0004
451 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 19 0.0004
452 INSOMNIA 105 0.0004
453 DRUG DOSE OMISSION 65 0.0004
454 DRUG LEVEL DECREASED 4 0.0004
455 INCORRECT ROUTE OF DRUG ADMINISTRATION 14 0.0004
456 DISSOCIATION 3 0.0004
457 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
458 DRUG TITRATION ERROR 1 0.0004
459 INTENTIONAL DOSE OMISSION 11 0.0004
460 HERNIA REPAIR 1 0.0004
461 SLEEP DISORDER 27 0.0004
462 NO ADVERSE EVENT 69 0.0004
463 EXFOLIATIVE RASH 1 0.0004
464 SUICIDE ATTEMPT 23 0.0004
465 FOOD POISONING 2 0.0004
466 BRUXISM 2 0.0004
467 ANORGASMIA 1 0.0004
468 INJECTION SITE REACTION 25 0.0004
469 INJECTION SITE INJURY 2 0.0004
470 DISCOMFORT 22 0.0004
471 ROAD TRAFFIC ACCIDENT 15 0.0004
472 MASS 5 0.0004
473 ANAL HAEMORRHAGE 1 0.0004
474 ACCIDENTAL OVERDOSE 13 0.0004
475 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
476 ERECTILE DYSFUNCTION 9 0.0004
477 DRUG ABUSE 29 0.0003
478 MUSCLE STRAIN 3 0.0003
479 SKIN SWELLING 3 0.0003
480 ESCHERICHIA SEPSIS 1 0.0003
481 SPEECH DISORDER 18 0.0003
482 MUSCULOSKELETAL STIFFNESS 30 0.0003
483 HEAD DISCOMFORT 6 0.0003
484 URINARY INCONTINENCE 10 0.0003
485 WRONG DRUG ADMINISTERED 3 0.0003
486 PRODUCT PRESCRIBING ERROR 8 0.0003
487 MYOCLONUS 4 0.0003
488 MUSCLE RIGIDITY 4 0.0003
489 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
490 ANAL INCONTINENCE 3 0.0003
491 EXPIRED PRODUCT ADMINISTERED 11 0.0003
492 EMERGENCY CARE 1 0.0003
493 INSURANCE ISSUE 5 0.0003
494 BLOOD GLUCOSE ABNORMAL 6 0.0003
495 BRAIN DEATH 1 0.0003
496 DYSARTHRIA 12 0.0003
497 PRODUCT PACKAGING ISSUE 3 0.0003
498 THERAPEUTIC RESPONSE CHANGED 2 0.0003
499 PRESCRIBED OVERDOSE 6 0.0003
500 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2 0.0003
501 CHOKING 6 0.0003
502 BREAST ENLARGEMENT 1 0.0003
503 THERAPY CHANGE 3 0.0003
504 PRODUCT PREPARATION ISSUE 2 0.0003
505 WALKING AID USER 2 0.0003
506 ANXIETY DISORDER 1 0.0003
507 DRUG EFFECT DECREASED 16 0.0003
508 LIMB INJURY 8 0.0003
509 MOTOR DYSFUNCTION 3 0.0003
510 BODY TEMPERATURE INCREASED 6 0.0003
511 PALLOR 8 0.0003
512 SCAR 5 0.0003
513 AMNESIA 19 0.0003
514 HEPATIC FIBROSIS 1 0.0003
515 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
516 GRANULOMA 1 0.0003
517 HYPOPNOEA 1 0.0003
518 POLLAKIURIA 12 0.0003
519 FORMICATION 2 0.0003
520 WEIGHT FLUCTUATION 3 0.0003
521 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
522 DEPRESSIVE SYMPTOM 1 0.0003
523 IMPAIRED WORK ABILITY 6 0.0003
524 DEVICE PLACEMENT ISSUE 1 0.0003
525 APPARENT DEATH 1 0.0003
526 BACK INJURY 3 0.0003
527 PRODUCT DISPENSING ERROR 6 0.0003
528 DEVICE KINK 1 0.0003
529 HYPOPHAGIA 7 0.0003
530 MAJOR DEPRESSION 2 0.0003
531 FOOT DEFORMITY 3 0.0003
532 AUTOIMMUNE THYROIDITIS 1 0.0003
533 ECONOMIC PROBLEM 4 0.0003
534 MEMORY IMPAIRMENT 36 0.0003
535 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
536 FEELING HOT 16 0.0003
537 NIGHTMARE 9 0.0003
538 LIMB DISCOMFORT 8 0.0003
539 CONCUSSION 2 0.0003
540 INJECTION SITE ERYTHEMA 32 0.0003
541 CERVIX CARCINOMA 1 0.0003
542 ABNORMAL DREAMS 7 0.0003
543 CONDITION AGGRAVATED 77 0.0003
544 SCIATICA 4 0.0003
545 SENSORY LOSS 2 0.0002
546 ENURESIS 1 0.0002
547 EXTRA DOSE ADMINISTERED 10 0.0002
548 MALAISE 108 0.0002
549 HICCUPS 2 0.0002
550 SEIZURE 28 0.0002
551 MUSCLE INJURY 2 0.0002
552 INJECTION SITE DISCOLOURATION 3 0.0002
553 GAIT INABILITY 8 0.0002
554 ERECTION INCREASED 1 0.0002
555 INJECTION SITE IRRITATION 3 0.0002
556 FACIAL PARALYSIS 2 0.0002
557 HEPATIC PAIN 1 0.0002
558 DRY MOUTH 19 0.0002
559 ABNORMAL SENSATION IN EYE 1 0.0002
560 BONE CANCER 1 0.0002
561 GAIT DISTURBANCE 44 0.0002
562 PRODUCT COMMUNICATION ISSUE 2 0.0002
563 ADVERSE REACTION 3 0.0002
564 BLOOD CREATINE INCREASED 1 0.0002
565 SWOLLEN TONGUE 7 0.0002
566 MUSCLE SPASMS 41 0.0002
567 DRUG EFFECT DELAYED 1 0.0002
568 DRUG EFFECT INCOMPLETE 8 0.0002
569 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
570 MENTAL STATUS CHANGES 6 0.0002
571 DEMENTIA 6 0.0002
572 BLOOD CHOLESTEROL INCREASED 10 0.0002
573 PRODUCT DOSE OMISSION ISSUE 62 0.0002
574 GESTATIONAL DIABETES 1 0.0002
575 HYPERHIDROSIS 27 0.0002
576 PARALYSIS 3 0.0002
577 ACCIDENTAL UNDERDOSE 3 0.0002
578 DRUG INEFFECTIVE 272 0.0002
579 DIZZINESS POSTURAL 2 0.0002
580 FIBROMYALGIA 5 0.0002
581 INJECTION SITE URTICARIA 5 0.0002
582 DISABILITY 4 0.0002
583 FOOT OPERATION 1 0.0002
584 BLOOD PRESSURE ABNORMAL 4 0.0002
585 ANEURYSM 1 0.0002
586 HYPOTONIA 2 0.0002
587 HYPERAMMONAEMIA 1 0.0002
588 SALIVARY HYPERSECRETION 2 0.0002
589 VAGINAL DISCHARGE 2 0.0002
590 DRUG TOLERANCE 1 0.0002
591 DYSPHORIA 1 0.0002
592 DYSLIPIDAEMIA 1 0.0002
593 FATIGUE 153 0.0002
594 TOOTH ABSCESS 2 0.0002
595 MOBILITY DECREASED 14 0.0002
596 TEMPERATURE INTOLERANCE 2 0.0002
597 ANKLE FRACTURE 3 0.0002
598 VENTRICULAR EXTRASYSTOLES 2 0.0002
599 RHABDOMYOLYSIS 8 0.0002
600 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
601 WITHDRAWAL SYNDROME 8 0.0002
602 RENAL PAIN 2 0.0002
603 EATING DISORDER 4 0.0002
604 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
605 PHARYNGITIS STREPTOCOCCAL 2 0.0002
606 HIP SURGERY 1 0.0002
607 ILLNESS 19 0.0002
608 ACCIDENTAL EXPOSURE TO PRODUCT 19 0.0002
609 OESOPHAGITIS 2 0.0002
610 JAW DISORDER 1 0.0002
611 FAECALOMA 1 0.0002
612 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
613 AUTISM SPECTRUM DISORDER 1 0.0002
614 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
615 HYPERKERATOSIS 1 0.0002
616 PRODUCT USE ISSUE 34 0.0002
617 STATUS EPILEPTICUS 2 0.0002
618 GRANULOCYTOPENIA 1 0.0002
619 MICTURITION URGENCY 2 0.0002
620 HYPOAESTHESIA 26 0.0002
621 HERPES VIRUS INFECTION 1 0.0002
622 EMOTIONAL DISTRESS 21 0.0002
623 ORTHOSTATIC HYPOTENSION 3 0.0002
624 DYSSTASIA 5 0.0002
625 AMENORRHOEA 3 0.0002
626 SPLENOMEGALY 2 0.0002
627 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
628 DIABETES MELLITUS 13 0.0002
629 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
630 ACCIDENT 2 0.0002
631 DEVICE ISSUE 15 0.0002
632 BLOOD PRESSURE FLUCTUATION 4 0.0002
633 GANGRENE 1 0.0002
634 TOOTHACHE 3 0.0002
635 HEPATITIS C 2 0.0002
636 INJECTION SITE RASH 5 0.0002
637 INJECTION SITE EXTRAVASATION 2 0.0002
638 HEPATIC CIRRHOSIS 3 0.0002
639 UNEVALUABLE EVENT 12 0.0002
640 DYSPHAGIA 15 0.0002
641 BLOOD URINE PRESENT 3 0.0002
642 MUSCULOSKELETAL DISORDER 3 0.0002
643 MIGRAINE 15 0.0002
644 DIZZINESS 78 0.0002
645 MYDRIASIS 2 0.0002
646 MOVEMENT DISORDER 5 0.0002
647 RASH GENERALISED 4 0.0002
648 HYPERPROLACTINAEMIA 1 0.0002
649 PALPITATIONS 18 0.0002
650 VISION BLURRED 21 0.0002
651 ANHEDONIA 4 0.0002
652 BEDRIDDEN 2 0.0002
653 DYSGRAPHIA 1 0.0002
654 PRESCRIBED UNDERDOSE 3 0.0002
655 ABORTION SPONTANEOUS 6 0.0001
656 PAIN IN EXTREMITY 44 0.0001
657 QUALITY OF LIFE DECREASED 2 0.0001
658 BREAST MASS 1 0.0001
659 CONFUSIONAL STATE 24 0.0001
660 DECREASED APPETITE 34 0.0001
661 ENCEPHALITIS 1 0.0001
662 APHONIA 2 0.0001
663 EXTRASYSTOLES 1 0.0001
664 DEFAECATION URGENCY 1 0.0001
665 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
666 HAND FRACTURE 1 0.0001
667 JOINT INJURY 3 0.0001
668 POOR QUALITY SLEEP 3 0.0001
669 IMPAIRED QUALITY OF LIFE 2 0.0001
670 CELLULITIS 7 0.0001
671 INJECTION SITE HAEMATOMA 2 0.0001
672 HYPOKINESIA 2 0.0001
673 PRODUCT PRESCRIBING ISSUE 3 0.0001
674 GASTROENTERITIS 2 0.0001
675 INTENTIONAL UNDERDOSE 1 0.0001
676 CEREBRAL DISORDER 1 0.0001
677 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
678 DRUG INTOLERANCE 13 0.0001
679 INFLUENZA LIKE ILLNESS 11 0.0001
680 CHROMATURIA 3 0.0001
681 HYPOAESTHESIA ORAL 2 0.0001
682 VOMITING 62 0.0001
683 ILL-DEFINED DISORDER 8 0.0001
684 HYPERTHERMIA 1 0.0001
685 BOWEL MOVEMENT IRREGULARITY 1 0.0001
686 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
687 THYROID DISORDER 2 0.0001
688 APHTHOUS ULCER 1 0.0001
689 APNOEA 1 0.0001
690 CYANOSIS 2 0.0001
691 HEAD INJURY 4 0.0001
692 FURUNCLE 1 0.0001
693 DISORIENTATION 5 0.0001
694 DISEASE RECURRENCE 6 0.0001
695 DRUG INTERACTION 20 0.0001
696 OBESITY 2 0.0001
697 ABSCESS 2 0.0001
698 BLOOD DISORDER 1 0.0001
699 BACK DISORDER 2 0.0001
700 WEIGHT DECREASED 34 0.0001
701 HYPERAESTHESIA 1 0.0001
702 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
703 AGEUSIA 3 0.0001
704 DRY EYE 6 0.0001
705 COMPLETED SUICIDE 10 0.0001
706 EOSINOPHIL COUNT INCREASED 1 0.0001
707 SYNCOPE 12 0.0001
708 ATRIAL SEPTAL DEFECT 1 0.0001
709 FACE OEDEMA 2 0.0001
710 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
711 NAUSEA 93 0.0001
712 UNRESPONSIVE TO STIMULI 3 0.0001
713 HYSTERECTOMY 1 0.0001
714 DEVICE LEAKAGE 5 0.0001
715 JOINT STIFFNESS 3 0.0001
716 PRODUCT STORAGE ERROR 10 0.0001
717 GROIN PAIN 1 0.0001
718 COLD SWEAT 2 0.0001
719 VISUAL IMPAIRMENT 14 0.0001
720 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
721 TACHYCARDIA 10 0.0001
722 FACIAL PAIN 1 0.0001
723 GASTROINTESTINAL INFECTION 1 0.0001
724 HEART RATE INCREASED 11 0.0001
725 PELVIC PAIN 2 0.0001
726 BONE DISORDER 2 0.0001
727 END STAGE RENAL DISEASE 2 0.0001
728 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
729 BACK PAIN 25 0.0001
730 HEPATIC STEATOSIS 2 0.0001
731 WOUND 3 0.0001
732 ABDOMINAL DISCOMFORT 18 0.0001
733 PHOTOPHOBIA 2 0.0001
734 HOT FLUSH 8 0.0001
735 BLOOD SODIUM DECREASED 2 0.0001
736 PAIN IN JAW 3 0.0001
737 FRACTURE 2 0.0001
738 RED BLOOD CELL COUNT DECREASED 3 0.0001
739 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
740 BALANCE DISORDER 9 0.0001
741 PERIPHERAL SWELLING 16 0.0001
742 HYPERCHOLESTEROLAEMIA 1 0.0001
743 NASOPHARYNGITIS 19 0.0001
744 COELIAC DISEASE 1 0.0001
745 KIDNEY INFECTION 2 0.0001
746 MENORRHAGIA 2 0.0001
747 BODY TEMPERATURE DECREASED 1 0.0001
748 BLADDER DISORDER 1 0.0001
749 MYALGIA 17 0.0001
750 BLOOD POTASSIUM DECREASED 3 0.0001
751 PREMATURE BABY 3 0.0001
752 APHASIA 3 0.0001
753 FEEDING DISORDER 2 0.0001
754 DEVICE BREAKAGE 4 0.0001
755 DRY THROAT 1 0.0001
756 BLOOD PRESSURE INCREASED 15 0.0001
757 INITIAL INSOMNIA 1 0.0001
758 EAR DISCOMFORT 1 0.0001
759 RIB FRACTURE 2 0.0001
760 FEMUR FRACTURE 3 0.0001
761 TREATMENT FAILURE 8 0.0001
762 EYE DISCHARGE 1 0.0001
763 ARTHRALGIA 40 0.0001
764 FOLLICULITIS 1 0.0001
765 MOUTH ULCERATION 2 0.0001
766 JOINT DISLOCATION 1 0.0001
767 HYPERTENSION 20 0.0001
768 BRADYCARDIA 5 0.0001
769 RETCHING 2 0.0001
770 LOSS OF CONSCIOUSNESS 12 0.0001
771 BODY HEIGHT DECREASED 1 0.0001
772 BREAST CANCER METASTATIC 1 0.0001
773 ABDOMINAL PAIN UPPER 19 0.0001
774 SWELLING FACE 6 0.0001
775 CHOLELITHIASIS 3 0.0001
776 IMPAIRED HEALING 3 0.0001
777 ASPIRATION 1 0.0001
778 TOOTH DISORDER 2 0.0001
779 INJECTION SITE PRURITUS 6 0.0001
780 HEADACHE 56 0.0001
781 SNEEZING 2 0.0001
782 BLOOD CALCIUM DECREASED 1 0.0001
783 EYE PAIN 5 0.0001
784 HEART RATE IRREGULAR 2 0.0001
785 MUSCULAR WEAKNESS 10 0.0001
786 ASTHENIA 33 0.0001
787 CONSTIPATION 19 0.0001
788 TINNITUS 4 0.0001
789 PAIN 53 0.0001
790 INJURY 6 0.0001
791 OCULAR HYPERAEMIA 4 0.0001
792 BLOOD IRON DECREASED 1 0.0001
793 ATAXIA 1 0.0001
794 BLOOD GLUCOSE DECREASED 4 0.0001
795 BURSITIS 1 0.0001
796 HYPERGLYCAEMIA 3 0.0001
797 FALL 27 0.0001
798 GENERALISED OEDEMA 1 0.0001
799 CYST 1 0.0001
800 BLOOD GLUCOSE INCREASED 15 0.0001
801 ABDOMINAL PAIN LOWER 2 0.0001
802 FLUID RETENTION 4 0.0001
803 CHEST DISCOMFORT 8 0.0001
804 PYREXIA 27 0.0001
805 ADVERSE DRUG REACTION 7 0.0001
806 URTICARIA 13 0.0001
807 SKIN ULCER 2 0.0001
808 IMMUNE SYSTEM DISORDER 1 0.0001
809 OROPHARYNGEAL PAIN 7 0.0001
810 DYSMENORRHOEA 1 0.0001
811 HYPERSENSITIVITY 14 0.0001
812 DEHYDRATION 10 0.0001
813 SWELLING 7 0.0001
814 HYPOTENSION 15 0.0001
815 MENSTRUATION IRREGULAR 2 0.0001
816 FREQUENT BOWEL MOVEMENTS 2 0.0001
817 PRODUCT QUALITY ISSUE 10 0.0001
818 IMPAIRED GASTRIC EMPTYING 1 0.0001
819 GINGIVAL BLEEDING 1 0.0001
820 CORONARY ARTERY OCCLUSION 1 0.0001
821 BURNING SENSATION 5 0.0001
822 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
823 DEVICE OCCLUSION 1 0.0001
824 DIALYSIS 1 0.0001
825 RECTAL HAEMORRHAGE 3 0.0001
826 ANGINA PECTORIS 2 0.0001
827 EYE IRRITATION 4 0.0001
828 VAGINAL HAEMORRHAGE 3 0.0001
829 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
830 DYSPHONIA 4 0.0001
831 BONE PAIN 4 0.0001
832 NASAL CONGESTION 4 0.0001
833 EPISTAXIS 5 0.0001
834 JOINT SWELLING 8 0.0001
835 BLOOD COUNT ABNORMAL 1 0.0001
836 ACNE 5 0.0001
837 VERTIGO 4 0.0001
838 SKIN IRRITATION 3 0.0001
839 DRUG DISPENSING ERROR 1 0.0001
840 NEPHROLITHIASIS 3 0.0001
841 SKIN DISCOLOURATION 3 0.0001
842 ADVERSE EVENT 6 0.0001
843 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
844 GYNAECOMASTIA 2 0.0001
845 EXPOSURE DURING PREGNANCY 4 0.0001
846 BRAIN FOG 1 0.0001
847 PARAESTHESIA 10 0.0001
848 HIP FRACTURE 2 0.0001
849 THROMBOSIS 5 0.0001
850 ALOPECIA 12 0.0001
851 STAPHYLOCOCCAL INFECTION 2 0.0001
852 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
853 DRUG LEVEL INCREASED 1 0.0001
854 BLOOD PRESSURE DECREASED 4 0.0001
855 DYSPNOEA 34 0.0001
856 LIP SWELLING 2 0.0001
857 COAGULOPATHY 1 0.0001
858 FUNGAL INFECTION 2 0.0001
859 URINARY RETENTION 2 0.0001
860 CHILLS 7 0.0001
861 CHEST PAIN 11 0.0001
862 HEPATIC ENZYME INCREASED 4 0.0001
863 THERAPY CESSATION 3 0.0001
864 HAEMATURIA 2 0.0001
865 ERYTHEMA 12 0.0001
866 DEVICE DEFECTIVE 1 0.0001
867 DELIRIUM 2 0.0001
868 ABDOMINAL DISTENSION 6 0.0001
869 HEART RATE DECREASED 2 0.0001
870 PANCREATITIS 3 0.0001
871 LYMPHADENOPATHY 2 0.0001
872 GALLBLADDER DISORDER 1 0.0001
873 DYSURIA 2 0.0001
874 CONJUNCTIVITIS 1 0.0001
875 DYSGEUSIA 4 0.0001
876 BACTERIAL INFECTION 1 0.0001
877 OXYGEN SATURATION DECREASED 3 0.0001
878 FOOT FRACTURE 1 0.0001
879 ACUTE RESPIRATORY FAILURE 1 0.0001
880 ERUCTATION 1 0.0001
881 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
882 HAEMORRHOIDS 1 0.0001
883 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
884 HAEMATOCRIT DECREASED 1 0.0001
885 COMPLICATION OF DEVICE INSERTION 1 0.0001
886 COUGH 14 0.0000
887 FLUSHING 5 0.0000
888 BLINDNESS 2 0.0000
889 NEUTROPHIL COUNT DECREASED 2 0.0000
890 TOXICITY TO VARIOUS AGENTS 8 0.0000
891 CEREBROVASCULAR ACCIDENT 8 0.0000
892 OVERDOSE 10 0.0000
893 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
894 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
895 MYOCARDIAL INFARCTION 8 0.0000
896 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
897 NEOPLASM MALIGNANT 3 0.0000
898 DIARRHOEA 29 0.0000
899 INFLUENZA 5 0.0000
900 GASTROINTESTINAL DISORDER 4 0.0000
901 THROAT IRRITATION 2 0.0000
902 THERAPY NON-RESPONDER 2 0.0000
903 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
904 DEATH 37 0.0000
905 CARDIAC DISORDER 4 0.0000
906 THERAPY INTERRUPTED 3 0.0000
907 PRODUCTIVE COUGH 2 0.0000
908 HEPATIC CANCER 1 0.0000
909 OEDEMA PERIPHERAL 5 0.0000
910 CEREBRAL INFARCTION 1 0.0000
911 LUNG DISORDER 2 0.0000
912 DYSPEPSIA 4 0.0000
913 ABASIA 1 0.0000
914 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
915 GASTRIC CANCER 1 0.0000
916 HAEMATEMESIS 1 0.0000
917 HAEMOGLOBIN DECREASED 4 0.0000
918 ANAPHYLACTIC SHOCK 1 0.0000
919 HAEMATOMA 1 0.0000
920 EXPOSURE VIA SKIN CONTACT 1 0.0000
921 DIPLOPIA 1 0.0000
922 GASTRITIS 1 0.0000
923 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
924 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
925 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
926 RASH PRURITIC 2 0.0000
927 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
928 OEDEMA 2 0.0000
929 MEDICATION ERROR 2 0.0000
930 FEELING COLD 1 0.0000
931 HAEMOPTYSIS 1 0.0000
932 RENAL IMPAIRMENT 3 0.0000
933 BLISTER 2 0.0000
934 HYPONATRAEMIA 2 0.0000
935 ASTHMA 4 0.0000
936 FLATULENCE 2 0.0000
937 COVID-19 6 0.0000
938 DRUG WITHDRAWAL SYNDROME 3 0.0000
939 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
940 SURGERY 2 0.0000
941 PNEUMONIA 11 0.0000
942 LABORATORY TEST ABNORMAL 1 0.0000
943 WHEEZING 2 0.0000
944 CORONARY ARTERY DISEASE 1 0.0000
945 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
946 BONE DENSITY DECREASED 1 0.0000
947 PRURITUS 12 0.0000
948 INTENTIONAL OVERDOSE 2 0.0000
949 CONTUSION 3 0.0000
950 DRUG DEPENDENCE 5 0.0000
951 RHINORRHOEA 2 0.0000
952 RENAL FAILURE 4 0.0000
953 URINARY TRACT INFECTION 5 0.0000
954 DEVICE MALFUNCTION 2 0.0000
955 PLATELET COUNT DECREASED 3 0.0000
956 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
957 CEREBRAL HAEMORRHAGE 1 0.0000
958 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
959 INFECTION 4 0.0000
960 RASH 12 0.0000
961 BRONCHITIS 2 0.0000
962 INTESTINAL OBSTRUCTION 1 0.0000
963 RHEUMATOID ARTHRITIS 3 0.0000
964 SKIN EXFOLIATION 2 0.0000
965 HYPOACUSIS 1 0.0000
966 DEVICE DISLOCATION 1 0.0000
967 INTENTIONAL PRODUCT MISUSE 2 0.0000
968 NEUTROPENIA 3 0.0000
969 ARRHYTHMIA 1 0.0000
970 NEUROPATHY PERIPHERAL 2 0.0000
971 COMA 1 0.0000
972 HYPOGLYCAEMIA 1 0.0000
973 SINUSITIS 2 0.0000
974 INFLAMMATION 1 0.0000
975 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
976 DEPENDENCE 1 0.0000
977 HAEMATOCHEZIA 1 0.0000
978 ANAPHYLACTIC REACTION 1 0.0000
979 SEPSIS 2 0.0000
980 HERPES ZOSTER 1 0.0000
981 ABDOMINAL PAIN 4 0.0000
982 BLOOD CREATININE INCREASED 1 0.0000
983 PSORIASIS 2 0.0000
984 DEVICE DIFFICULT TO USE 1 0.0000
985 DRY SKIN 2 0.0000
986 CHRONIC KIDNEY DISEASE 1 0.0000
987 CARDIAC FAILURE CONGESTIVE 1 0.0000
988 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
989 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
990 HAEMORRHAGE 1 0.0000
991 DISEASE PROGRESSION 1 0.0000
992 ANAEMIA 1 0.0000